CV Quiz Flashcards
Ramipril is different from valsartan in which of the following ways:
A. It is not recommended for patients with heart failure
B. It directly reduces the amount of aldosterone released
C. It can decrease potassium levels
D. It lowers the level of circulating angiotensin II
E. It lowers BP more than valsartan
D.
Irbesartan should NOT be used in patients with the following problems:
A. Chronic kidney disease
B. Heart failure with preserved ejection fraction
C. Allergy to sulfa
D. Bilateral renal artery stenosis
E. Systolic BP less than 110mmHg
D.
A patient asks you for assistance in dealing with a dry cough that has been bothering him for weeks. Which of the following drugs might be causing this problem?
A. Trandolapril
B. Olmesartan
C. Chlorthalidone
D. Furosemide
E. Amlodipine
A.
A patient started losartan last week and has returned for a follow-up blood test. Which of the following changes could have been caused by losartan over the past week?
A. Decrease in potassium from 4.2mmol/L to 3.8mmol/L
B. Increase in serum creatinine from 75mmol/L to 94mmol/L
C. Decrease in systolic blood pressure from 157mmHg to 122mmHg
D. Increase in blood sugar from 5.2mmol/L to 6.5mmol/L
E. All of the above could happen in 1 week
B.
A patient has a high potassium level of 5.7mmol per Litre. Which of the following drugs should not be prescribed:
A. Furosemide
B. Amlodipine
C. Verapamil
D. Perindopril
E. None of these drugs should be prescribed
D.
Metoprolol’s primary effect is to interrupt which of the following physiologic systems?
A. RAAS
B. Central nervous system neurotransmitters
C. Parasympathetic nervous system
D. Sympathetic nervous system
E. Hypothalamic-pituitary axis
D.
Carvedilol is unique because it has which of the following properties
A. It is a selective beta-1 receptor antagonist
B. It is a non-selective beta-1 and beta-2 antagonist
C. It is a non-selective beta antagonist and an alpha-1 antagonist
D. It has agonist properties on the beta-2 receptor
E. It is a selective beta-1 antagonist and a alpha-2 receptor agonist
C.
Atenolol should NOT be used in people with which of the following conditions?
A. 2nd degree heart block
B. Heart rate below 80 beats per minute
C. Chronic kidney disease
D. Well controlled asthma
E. Heart failure with left ventricular systolic dysfunction
A.
A patient with diabetes did not notice an episode of low blood sugar recently. Which of her drugs may have contributed to her lack of awareness?
A. Ticagrelor
B. L. thyroxine
C. Rosuvastatin
D. Lisinopril
E. Metoprolol
E.
The primary target of amlodipine is on which of the following tissues?
A. Cardiac smooth muscle
B. Vascular smooth muscle
C. Renal tubules (i.e., kidney)
D. Adrenal gland
E. Central nervous system
B.
A patient taking amlodipine should be advised that one of the following effects may occur:
A. Increased blood pressure
B. Increased heart rate
C. Swelling of the ankles
D. Increased potassium
E. Increase in blood sugar
C.
When counselling on the use of verapamil, the pharmacist should include which of the following side effects?
A. Constipation
B. Fast heart rate
C. Low calcium levels
D. Increased potassium levels
E. Angina
A.
Which of the following medications should be AVOIDED if possible in a person taking verapamil?
A. ASA
B. Clarithromycin
C. Rosuvastatin
D. Nitroglycerin
E. Levothyroxine
B.
Diltiazem should be considered in which of the following clinical situations?
A. To treat ongoing angina during an acute coronary syndrome
B. To convert atrial fibrillation to normal sinus rhythm
C. To treat stable angina in a patient with normal heart function
D. To treat hyperglycemia associated with type-2 diabetes
E. To treat heart failure associated with left ventricular systolic dysfunction
C.
Which of the following medications inhibits sodium reabsorption in the distal tubule of the nephron?
A. Furosemide
B. Amiloride
C. Perindopril
D. Aliskiren
E. Indapamide
E.
Which of the following medications would be expected to exert the strongest diuretic activity?
A. Furosemide
B. Triamterene
C. Chlorthalidone
D. Eplerenone
E. Acetazolamide
A.
Which of the following laboratory test results are most likely to occur in a patient taking hydrochlorothiazide?
A. Low sodium
B. Low potassium
C. Low uric acid
D. Low glucose
E. Low hemoglobin
B.
Spironolactone may cause which of the following physiologic changes?
A. Gout
B. High blood pressure
C. High potassium
D. High blood sugar
E. Low sodium
C.
Under which of the following circumstances would hydrochlorothiazide be considered an inappropriate treatment option?
A. If potassium is high
B. If GFR is 18ml/min
C. In isolated systolic hypertension
D. If a patient has diabetes
E. If patient already taking an angiotensin receptor blocker
B.
After receiving a dose of clonidine, all of the following actions would be expected EXCEPT:
A. Reduced sympathetic nervous system activity in the CNS
B. Lower blood pressure
C. Lower heart rate
D. Fatigue or tiredness
E. All of the above would be expected
E.
Monitoring plans for people using hydralazine should include the following parameters:
A. ECG (i.e., onset of atrial fibrillation)
B. Angina
C. Fasting blood sugar
D. Orthostatic hypotension
E. Uric acid
D.
In a person with left ventricular hypertrophy, which of the following medications should be considered?
A. All HF medications for people with reduced ejection fraction (i.e., systolic heart failure)
B. A DOAC medication to prevent cardioembolic stroke
C. An antihypertensive medication if BP is high
D. A statin because of damage from prior ACS
E. A loop diuretic to minimize fluid accumulation
C.
In a person who has not achieved their BP targets despite taking ramipril, atenolol, chlorthalidone, and amlodipine, what would be the best option to add to the regimen?
A. Spironolactone
B. Hydralazine
C. Clonidine
D. Doxazosin
E. Valsartan
A.
Low-dose ASA is indicated for the protection against ischemic events such as MI and stroke. What is the mechanism responsible for this action?
A. Vasodilation
B. ADP receptor inhibitition
C. Inhibition of thromboxane A2 production
D. Prostacyclin inhibition
E. Factor Xa inhibition
C.